New drug aims to lift fatigue and brain fog in liver disease patients
Symptom relief
Recruiting now
This study tests a drug called golexanolone in 84 people with primary biliary cholangitis (PBC) who suffer from significant fatigue and cognitive problems. Participants receive either the drug or a placebo for up to 28 days. The goal is to see if the drug is safe and can improve …
Phase: PHASE1, PHASE2 • Sponsor: Umecrine Cognition AB • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC